About Achim

Mr. Achim Kautz was one of the founding Members of the European Liver Patients Association (ELPA) in 2004 and since 2001 has worked for Deutsche Leberhilfe e. V. of which he was the CEO till 2013. He has been a Member of the Board of the German Network of Excellence for Viral Hepatitis (Hep-Net) since 2002, Chairman of the Board of BAG Leber e. V. since 2003, and Member of the Board of Trustees of the Deutsche Leberstiftung since 2006. In 2008 he became a Member of the World Hepatitis Alliance and in 2010 he was among the founding members of the German workgroup “National Liver Strategy Plan”. In 2011 and 2012 he was the Vice-President of ELPA, in 2013 and 2014 the Policy Director. In 2014 he founded his own company “Asaldo Consulting LTD” but also the NGO Leberhilfe Projekt gUG which takes care of essential patient projects. He is now since 2015 the special Policy Consultant of ELPA and WHA and involved in some WHO groups.

This speaker will be presenting at the following session(s)

  • Policy as a tool for HepC Elimination


    Day: 1 November

    Time: 17:30

    Hepatitis C virus (HCV) infection is considered a major Public Health threat in Europe.

    Hepatitis C virus (HCV) infection is considered a major Public Health threat in Europe. Hepatitis C is a chronic infectious disease with great impact on patients’ morbidity and mortality, with high risk of progression to cirrhosis and liver cancer. In Europe, it is estimated that only 25% of patients with hepatitis C are diagnosed (~14 million people); each year there are 27,000-29,000 newly diagnosed HCV cases in the EU/EEA. Evidence shows that, for some European countries, annual deaths from hepatitis c have quadrupled over the past 20 years. New treatments were recently discovered that cures hepatitis C in up to 97% of cases. This, alongside the devastating effects that the disease can have, means that the paradigm at the community level of hepatitis c treatment should now be elimination.


    • From policy to action.
      Charles Gore, World Hepatitis Alliance
    • What matters to patients - HepCore.
      Prof. Jeffrey Lazarus, University of Copenhagen
    • Empowering advocates.
      Achim Kautz, Leberhilfe Projekt gUG
    • Modelling for policy change.
      Dr. Homie A. Razavi, Center for Disease Analysis Foundation
    • Brazil strategy and response to HCV.
      Evaldo Stanislau Affonso de Araújo, Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo
    • Let's End HepC Dashboard - assessing and comparing different Countries policies in real-time towards the elimination of HCV until 2030.
      Ricardo Baptista Leite, Member of the Portuguese Parliament and Católica University of Portugal